Materias dentro de su búsqueda.
Mostrando 485,981 - 486,000 Resultados de 487,202 Para Buscar '"free will"', tiempo de consulta: 2.34s Limitar resultados
  1. 485981
    “…The IRL classifier could availably classify patients into the low-risk and high-risk groups based on the different endpoints, including recurrence-free survival (RFS) and overall survival (OS). In terms of predictive ability and clinical utility, the IRL classifier was superior to other clinical characteristics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma
  2. 485982
    por Palanimuthu, Asvinkumar
    Publicado 2022
    “…In the sessions, possible causes of these symptoms were discussed, his family members were also psycho-educated about the psychosomatic nature of the symptoms and advised to encourage him for a symptom-free lifestyle. They were also given an instruction not to pay attention to his complaints of physical nature. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Case Report on Dissociative Quadriplegia
  3. 485983
    “…Hemolysis assay and acute toxicity studies with drug-free and doxorubicin lipid nanocarrier formulations provided evidence for their non-toxic nature. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug Delivery
  4. 485984
    “…Behaviour change regarding malaria treatment and free medication for children under five were the main reasons for participants to seek care at health centres. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso
  5. 485985
    “…The association of blood and tissue-based biomarkers, with overall survival (OS), progression-free survival (PFS) and response was analyzed. RESULTS: Among the 44 patients, baseline unswitched memory B cells (NSwM B cells) were enriched in responders (p=0.006) and associated with improved OS (HR=0.08, p=0.002) and PFS (HR=0.54, p=0.048). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
  6. 485986
    “…Forest plots were created to compare overall survival (OS) and relapse free survival (RFS) between ipi and HDI. Gene expression profiling (GEP) was performed on tumors of 718 (454 male, 264 female) patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males
  7. 485987
    por Lamoureux, Audrey-Anne, Fisher, Michael, Lemelle, Lauriane, Pfaff, Elke, Kramm, Christof, De Wilde, Bram, Kazanowska, Bernarda, Hutter, Caroline, Pfister, Stefan M, Sturm, Dominik, Jones, David, Orbach, Daniel, Pierron, Gaëlle, Raskin, Scott, Drilon, Alexander, Diamond, Eli, Harada, Guilherme, Zapotocky, Michal, Ellezam, Benjamin, Weil, Alexander G, Venne, Dominic, Barritault, Marc, Leblond, Pierre, Coltin, Hallie, Hammad, Rawan, Tabori, Uri, Hawkins, Cynthia, Hansford, Jordan R, Meyran, Deborah, Erker, Craig, McFadden, Kathryn, Sato, Mariko, Gottardo, Nicholas G, Dholaria, Hetal, Nørøxe, Dorte Schou, Goto, Hiroaki, Ziegler, David S, Lin, Frank Y, Parsons, Donald Williams, Lindsay, Holly, Wong, Tai-Tong, Liu, Yen-Lin, Wu, Kuo-Sheng, Franson, Andrea Flynn, Hwang, Eugene, Aguilar-Bonilla, Ana, Cheng, Sylvia, Cacciotti, Chantel, Massimino, Maura, Schiavello, Elisabetta, Wood, Paul, Hoffman, Lindsey M, Cappellano, Andréa, Lassaletta, Alvaro, Van Damme, An, Llort, Anna, Gerber, Nicolas U, Ceruso, Mariella Spalato, Bendel, Anne E, Skrypek, Maggie, Hamideh, Dima, Mushtaq, Naureen, Walter, Andrew, Jabado, Nada, Alsahlawi, Aysha, Farmer, Jean-Pierre, Abadi, Christina Coleman, Mueller, Sabine, Mazewski, Claire, Aguilera, Dolly, Robison, Nathan, O’Halloran, Katrina, Abbou, Samuel, Berlanga, Pablo, Geoerger, Birgit, Øra, Ingrid, Moertel, Christopher L, Razis, Evangelia D, Vernadou, Anastasia, Doz, François, Laetsch, Theodore W, Perreault, Sébastien
    Publicado 2022
    “…For LGG the median progression-free survival (PFS) after the first line of treatment was 17 months (95% CI: 0.0-35.5) and median overall survival (OS) was not reached. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
  8. 485988
    “…The clinical outcome seems to be very encouraging with 1-year local control (LC), overall survival (OS) and progression-free survival (PFS) rates ranging from 84 to 94%, 53 to 88% and 23 to 53.9%, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review
  9. 485989
    por Gilles, Liese, Govarts, Eva, Rodriguez Martin, Laura, Andersson, Anna-Maria, Appenzeller, Brice M. R., Barbone, Fabio, Castaño, Argelia, Coertjens, Dries, Den Hond, Elly, Dzhedzheia, Vazha, Eržen, Ivan, López, Marta Esteban, Fábelová, Lucia, Fillol, Clémence, Franken, Carmen, Frederiksen, Hanne, Gabriel, Catherine, Haug, Line Småstuen, Horvat, Milena, Halldórsson, Thórhallur Ingi, Janasik, Beata, Holcer, Nataša Janev, Kakucs, Réka, Karakitsios, Spyros, Katsonouri, Andromachi, Klánová, Jana, Kold-Jensen, Tina, Kolossa-Gehring, Marike, Konstantinou, Corina, Koponen, Jani, Lignell, Sanna, Lindroos, Anna Karin, Makris, Konstantinos C., Mazej, Darja, Morrens, Bert, Murínová, Ľubica Palkovičová, Namorado, Sónia, Pedraza-Diaz, Susana, Peisker, Jasmin, Probst-Hensch, Nicole, Rambaud, Loïc, Rosolen, Valentina, Rucic, Enrico, Rüther, Maria, Sarigiannis, Dimosthenis, Tratnik, Janja Snoj, Standaert, Arnout, Stewart, Lorraine, Szigeti, Tamás, Thomsen, Cathrine, Tolonen, Hanna, Eiríksdóttir, Ása, Van Nieuwenhuyse, An, Verheyen, Veerle J., Vlaanderen, Jelle, Vogel, Nina, Wasowicz, Wojciech, Weber, Till, Zock, Jan-Paul, Sepai, Ovnair, Schoeters, Greet
    Publicado 2022
    “…In October 2020 the EU commission published its new chemicals strategy for sustainability towards a toxic-free environment. The European Parliament called upon the commission to collect human biomonitoring data to support chemical’s risk assessment and risk management. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants
  10. 485990
    “…Despite adjustment for the three most important prognostic patient characteristics, namely female age, duration of subfertility and primary or secondary subfertility, our estimates might not be free from residual confounding. WIDER IMPLICATIONS OF THE FINDINGS: IVF should be used selectively based on judgements on gain compared to continuing expectant management for a given couple. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    IVF for unexplained subfertility; whom should we treat?
  11. 485991
    “…BACKGROUND: The combination of transcatheter arterial chemoembolization (TACE) plus sorafenib prolonged progression-free survival (PFS) and overall survival (OS) than sorafenib or TACE monotherapy for patients with hepatocellular carcinoma (HCC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study
  12. 485992
    “…The Centres for Disease Control light trap (CDC-LT) and the human decoy trap (HDT) are exposure-free alternatives. This study compared the CDC-LT and HDT against HLC for measuring Anopheles biting in rural Tanzania and assessed their suitability as HLC proxies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Centres for Disease Control light trap (CDC-LT) and the human decoy trap (HDT) compared to the human landing catch (HLC) for measuring Anopheles biting in rural Tanzania
  13. 485993
    “…Compared to the NUSAP1 low expression group, the NUSAP1 high expression group was more likely to also have lymph node metastasis, pathological PTC type, shorter progression-free survival (PFS), and higher scores for immune checkpoint inhibitor treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors
  14. 485994
    “…RESULTS: AKT1 and CDH1 mutations were identified as independent predictors of poor progression-free survival (PFS) and primary resistance to ICIs in dMMR/MSI-H GI cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
  15. 485995
    “…MAIN OUTCOMES AND MEASURES: Association of TMB levels with objective response rate (ORR), progression-free survival (PFS), and overall survival (OS). RESULTS: In the entire cohort of 1552 patients with advanced NSCLC who received PD-1/PD-L1 blockade, the median (range) age was 66 (22-92) years, 830 (53.5%) were women, and 1347 (86.8%) had cancer with nonsquamous histologic profile. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
  16. 485996
    “…A total of 57,586 women (57,708 pregnancies) from all 39 counties of Chongqing who participated in the National Free Preconception Health Examination Project were included. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Preconception reproductive tract infections status and adverse pregnancy outcomes: a population-based retrospective cohort study
  17. 485997
    “…BACKGROUND: Radiotherapy using the deep inspiration breath-hold (DIBH) technique compared with free breathing (FB) can achieve substantial reduction of heart and lung doses in left-sided breast cancer cases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis
  18. 485998
    “…BACKGROUND: The randomized phase 3 COMBI-i trial did not meet its primary endpoint of improved progression-free survival (PFS) with spartalizumab plus dabrafenib and trametinib (sparta-DabTram) vs placebo plus dabrafenib and trametinib (placebo-DabTram) in the overall population of patients with unresectable/metastatic BRAF V600-mutant melanoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
  19. 485999
    “…RESULTS: In all, 199 patients underwent conservative surgery and SLN biopsy; 133 patients meeting criteria were analysed: 41 patients (30.8%) pN1mic and 92 (69.2%) pN1a. The 5‑year disease-free survival (DFS) was 95.0% (85.9–100%) in group 1 and 93.0% (86.3–100.0%) in group 2 (p = 0.78). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial
  20. 486000
    “…Selected-ion monitoring of m/z 811 and m/z 814 was used in quantitative analyses. Free Hyp was found in spot urine samples (10 µL) of two healthy subjects at 0.60 µM (0.29 µmol Hyp/mmol creatinine) in the female and 1.80 µM (0.19 µmol Hyp/mmol creatinine) in the male subject. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Specific and sensitive GC–MS analysis of hypusine, N(ε)-(4-amino-2-hydroxybutyl)lysine, a biomarker of hypusinated eukaryotic initiation factor eIF5A, and its application to the bi-ethnic ASOS study
Herramientas de búsqueda: RSS